AAAAAA

   
Results: 1-13 |
Results: 13
GABAergic neuronal subtypes in the human frontal cortex - development and deficits in schizophrenia
Authors: Reynolds, GP Beasley, CL
Citation: Gp. Reynolds et Cl. Beasley, GABAergic neuronal subtypes in the human frontal cortex - development and deficits in schizophrenia, J CHEM NEUR, 22(1-2), 2001, pp. 95-100
Neurochemical correlates of cortical GABAergic deficits in schizophrenia: Selective losses of calcium binding protein immunoreactivity
Authors: Reynolds, GP Zhang, ZJ Beasley, CL
Citation: Gp. Reynolds et al., Neurochemical correlates of cortical GABAergic deficits in schizophrenia: Selective losses of calcium binding protein immunoreactivity, BRAIN RES B, 55(5), 2001, pp. 579-584
Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells
Authors: Reynolds, LM Dalton, CF Reynolds, GP
Citation: Lm. Reynolds et al., Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells, NEUROSCI L, 309(3), 2001, pp. 193-196
Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia
Authors: Nudmamud, S Reynolds, GP
Citation: S. Nudmamud et Gp. Reynolds, Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia, NEUROSCI L, 304(1-2), 2001, pp. 9-12
Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia
Authors: Zhang, ZJ Reynolds, GP Ramchand, CN Peet, M Shah, S
Citation: Zj. Zhang et al., Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia, ACT PHAR SI, 22(1), 2001, pp. 76-80
Plasma homovanillic acid in untreated schizophrenia - relationship with symptomatology and sex
Authors: Zhang, ZJ Peet, M Ramchand, CN Shah, S Reynolds, GP
Citation: Zj. Zhang et al., Plasma homovanillic acid in untreated schizophrenia - relationship with symptomatology and sex, J PSYCH RES, 35(1), 2001, pp. 23-28
Pharmacological management of neurological and psychiatric disorders
Authors: Reynolds, GP
Citation: Gp. Reynolds, Pharmacological management of neurological and psychiatric disorders, AM J PSYCHI, 158(9), 2001, pp. 1539-1540
Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS
Authors: Sardar, AM Hutson, PH Reynolds, GP
Citation: Am. Sardar et al., Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS, NEUROREPORT, 10(17), 1999, pp. 3513-3515
Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens
Authors: Dalley, JW Thomas, KL Howes, SR Tsai, TH Aparicio-Legarza, MI Reynolds, GP Everitt, BJ Robbins, TW
Citation: Jw. Dalley et al., Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens, EUR J NEURO, 11(4), 1999, pp. 1265-1274
Dopamine receptors, antipsychotic action and schizophrenia
Authors: Reynolds, GP
Citation: Gp. Reynolds, Dopamine receptors, antipsychotic action and schizophrenia, J PSYCHOPH, 13(2), 1999, pp. 202-203
Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation
Authors: Reynolds, GP Dalton, CF Tillery, CL Mangiarini, L Davies, SW Bates, GP
Citation: Gp. Reynolds et al., Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation, J NEUROCHEM, 72(4), 1999, pp. 1773-1776
Agonist-stimulated GTP gamma[S-35] binding to 5-HT1A receptors in human post-mortem brain
Authors: Elliott, J Reynolds, GP
Citation: J. Elliott et Gp. Reynolds, Agonist-stimulated GTP gamma[S-35] binding to 5-HT1A receptors in human post-mortem brain, EUR J PHARM, 386(2-3), 1999, pp. 313-315
Drug action in the nervous system
Authors: Reynolds, GP
Citation: Gp. Reynolds, Drug action in the nervous system, AM J PSYCHI, 156(9), 1999, pp. 1459-1459
Risultati: 1-13 |